Regression of Fibrosis & Reversal of Diastolic Dysfunction in HFpEF Patients Treated With Allogeneic CDCs
Clinical trial NCT02941705 · COMPLETED
Trial details
- NCT number
- NCT02941705
- Sponsor
- Cedars-Sinai Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-12
- Primary completion
- 2023-04-28
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.